Ryushi Tazawa

Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth.

Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.

Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction.

[Gene therapy and clinical trials].

N-terminal deletion augments the cell-death-inducing activity of BAX in adenoviral gene delivery to nonsmall cell lung cancers.

[Relapsing polychondritis with idiopathic hypoparathyroidism].

Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.

Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF.

Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.

Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.

Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan.

Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.

Acute-onset sarcoidosis with erythema nodosum and polyarthralgia (Löfgren's syndrome) in Japan: a case report and a review of the literature.

Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis.

[A case of pulmonary Langerhans cell histiocytosis discovered by CT mass screening and followed by bronchoalveolar lavage].

Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis.

Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.

A cell-free assay to estimate the neutralizing capacity of granulocyte-macrophage colony-stimulating factor autoantibodies.

Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB.

[autoimmune pulmonary alveolar proteinosis and GM-CSF inhalation therapy].

Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.